+$4.58 (+4.2%)
Closing price August 10, 2020
GW Pharmaceuticals shares popped early on Monday morning after the company announced that it received a key approval from the FDA for Epidiolex to treat certain seizures.
GW Pharmaceuticals took a big step forward for the development of its cannabidiol product in the United Kingdom.